As a colorectal cancer surgeon, I can tell you the answer is, yes — plenty. In fact, it's thought that more than half of cases in the UK are preventable. So what can you do to stop the disease ...
Overall colon cancer rates in the United States have declined steadily over the last 30 years. But rates of colon cancer in young adults have risen dramatically during this period for unknown reasons.
Colon cancer, which affects the large intestine, is one of the most common cancers in the United States. Medical experts typically group it with rectal cancer in a category called colorectal cancer.
Aug. 14, 2024 — A new study has identified diet-derived molecules called metabolites as main drivers of young-onset colorectal cancer risk, especially those associated with red and processed meat.
As anesthesia was wearing off, the doctor was holding up a photo of his colon and speaking to him and his wife. “I was just taken aback because I knew exactly what it was. There was no question ...
Colorectal cancer, also known as bowel cancer, is a cancer formed by uncontrolled cell growth in the colon or rectum (parts of the large intestine), or in the appendix. Genetic analysis shows that ...
The most common form of colorectal cancer, microsatellite-stable colorectal cancer (MSS CRC), can currently only be treated to a limited extent with modern immunotherapies. A research team led by ...
A video series where directors comment on the craft of movie-making. ‘Transformers One’ | Anatomy of a Scene The director Josh Cooley narrates a sequence from his film. By Mekado Murphy ...
A new treatment for locally advanced rectal cancer shows favourable results in that surgery can sometimes be avoided completely. It also reduces the risk of recurrence. The method has been ...
An insider guide to 48 hours in Spain’s steamy southern city, home to fabulous food, extraordinary architecture and exotic ...
Colon cancer is the disease characterized by the development of malignant cells in the lining or epithelium of the first and longest portion of the large intestine. In the phase 2 NICHE-3 trial ...